Skip Nav Destination
Issues
1 October 2000
ISSN 1078-0432
EISSN 1557-3265
Editorial
Minireview
Advances in Brief
Clinical Trials
A Phase I Radioimmunotherapy Trial Evaluating 90Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies1
Jeffrey Y. C. Wong; David Z. Chu; Dave M. Yamauchi; Lawrence E. Williams; An Liu; Sharon Wilczynski; Anna M. Wu; John E. Shively; James H. Doroshow; Andrew A. Raubitschek
Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients1
Al B. Benson, III; Olufunmilayo I. Olopade; Mark J. Ratain; Alfred Rademaker; Sohrab Mobarhan; Lisa Stucky-Marshall; Suzanne French; M. Eileen Dolan
Phase III Randomized Study of Postradiotherapy Chemotherapy with α-Difluoromethylornithine-Procarbazine, N-(2-Chloroethyl)-N′-cyclohexyl-N-nitrosurea, Vincristine (DFMO-PCV) Versus PCV for Glioblastoma Multiforme1
Victor A. Levin; Joon H. Uhm; Kurt A. Jaeckle; Ali Choucair; Patrick J. Flynn; W. K. Alfred Yung; Michael D. Prados; Janet M. Bruner; Susan M. Chang; Athanassios P. Kyritsis; Mary Jo Gleason; Kenneth R. Hess
Molecular Oncology, Markers, Clinical Correlates
Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma1
Alison T. Stopeck; Andrea Gessner; Thomas P. Miller; Evan M. Hersh; Cynthia S. Johnson; Haiyan Cui; Yvette Frutiger; Thomas M. Grogan
Different Patterns of Allelic Loss (Loss of Heterozygosity) in Recurrent Human Pituitary Tumors Provide Evidence for Multiclonal Origins1
Richard N. Clayton; Marija Pfeifer; A. Brew Atkinson; Paul Belchetz; John A. H. Wass; Effie Kyrodimou; Mark Vanderpump; David Simpson; John Bicknell; William E. Farrell
High Frequency of Clonally Related Tumors in Cases of Multiple Synchronous Lung Cancers as Revealed by Molecular Diagnosis1
Shigeki Shimizu; Yasushi Yatabe; Takashi Koshikawa; Nobuhiro Haruki; Shunzo Hatooka; Masayuki Shinoda; Motokazu Suyama; Makoto Ogawa; Nobuyuki Hamajima; Ryuzo Ueda; Takashi Takahashi; Tetsuya Mitsudomi
The Evolution of Loss of Heterozygosity on Chromosome 17 during the Progression to Barrett’s Adenocarcinoma Involves a Unique Combination of Target Sites in Individual Specimens1
Julie R. Dunn; Julie Garde; Kevin Dolan; John R. Gosney; Beverly C. Oates; Alastair J. M. Watson; Patricia Fielding; John K. Field
Expression of Prostate-specific Membrane Antigen in Transitional Cell Carcinoma of the Bladder: Prognostic Value?1
Jean-Luc Gala; Sylvain Loric; Yves Guiot; Samuel Ray Denmeade; Alyssa Gady; Francis Brasseur; Michel Heusterspreute; Pascal Eschwège; Philippe De Nayer; Paul Van Cangh; Bertrand Tombal
Study of Dose Escalation and Sequence Switching of Administration of the Combination of Docetaxel and Doxorubicin in Advanced Breast Cancer
Kuniaki Itoh; Yasutsuna Sasaki; Hirofumi Fujii; Hironobu Minami; Tomoko Ohtsu; Hisashi Wakita; Tadahiko Igarashi; Yuko Watanabe; Yusuke Onozawa; Masaki Kashimura; Yasuo Ohashi
Analysis of Genetic Polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese Patients with Therapy-related Leukemia/Myelodysplastic Syndrome and de novo Acute Myeloid Leukemia1
Tomoki Naoe; Kunihiko Takeyama; Toshiya Yokozawa; Hitoshi Kiyoi; Masao Seto; Naokuni Uike; Teruo Ino; Atae Utsunomiya; Atsuo Maruta; Itsuro Jin-nai; Nanao Kamada; Yoshitsugu Kubota; Hiroyuki Nakamura; Chihiro Shimazaki; Shigeo Horiike; Yoshihisa Kodera; Hidehiko Saito; Ryuzo Ueda; Joseph Wiemels; Ryuzo Ohno
Experimental Therapeutics, Preclinical Pharmacology
Prostate Cancer Gene Therapy: Comparison of Adenovirus-mediated Expression of Interleukin 12 with Interleukin 12 plus B7-1 for in Situ Gene Therapy and Gene-modified, Cell-based Vaccines1
Gerald W. Hull; Mark A. McCurdy; Yasutomo Nasu; Chris H. Bangma; Guang Yang; Satoru Shimura; Hon-Man Lee; Jianxiang Wang; Justin Albani; Shin Ebara; Takefumi Sato; Terry L. Timme; Timothy C. Thompson
Antitumor Activity of Temozolomide Combined with Irinotecan Is Partly Independent of O6-Methylguanine-DNA Methyltransferase and Mismatch Repair Phenotypes in Xenograft Models1
Peter J. Houghton; Clinton F. Stewart; Pamela J. Cheshire; Lois B. Richmond; Mark N. Kirstein; Catherine A. Poquette; Ming Tan; Henry S. Friedman; Thomas P. Brent
Letters to the Editor
Advertisement